Sedative, Hypnotic, or Anxiolytic Use Disorder
A. A problematic pattern of sedative, hypnotic, or anxiolytic use leading to clinically signif- icant impairment or distress, as manifested by at least two of the following, occurring within a 12-month period: 1.
2.
Sedatives, hypnotics, or anxiolytics are often taken in larger amounts or over a lon- ger period than was intended.
There is a persistent desire or unsuccessful efforts to cut down or control sedative, hypnotic, or anxiolytic use.
A great deal of time is spent in activities necessary to obtain the sedative, hypnotic, or anxiolytic; use the sedative, hypnotic, or anxiolytic; or recover from its effects.
Craving, or a strong desire or urge to use the sedative, hypnotic, or anxiolytic.
Recurrent sedative, hypnotic, or anxiolytic use resulting in a failure to fulfill major role obligations at work. school, or home (e.g., repeated absences from work or poor work performance related to sedative, hypnotic, or anxiolytic use; sedative-, hypnotic-, or anxiolytic-related absences, suspensions, or expulsions from school; neglect of children or household).
Continued sedative, hypnotic, or anxiolytic use despite having persistent or re- current social or interpersonal problems caused or exacerbated by the effects of sedatives, hypnotics, or anxiolytics (e.g., arguments with a spouse about conse- quences of intoxication; physical tights).
Important social, occupational, or recreational activities are given up or reduced be- cause of sedative. hypnotic, or anxiolytic use.
Sedative, Hypnotic, or Anxiolytic Use Disorder 551 8. Recurrent sedative, hypnotic, or anxiolytic use in situations in which it is physically hazardous (e.g., driving an automobile or operating a machine when impaired by sedative, hypnotic, or anxiolytic use).
9. Sedative. hypnotic, or anxiolytic use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the sedative, hypnotic, or anxiolytic.
10. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the sedative, hypnotic, or anxiolytic to achieve intoxication or desired effect.
b. A markedly diminished effect with continued use of the same amount of the sed- ative, hypnotic, or anxiolytic.
Note: This criterion is not considered to be met for individuals taking sedatives, hypnotics, or anxiolytics under medical supervision.
11. Withdrawal, as manifested by either of the following: a. The characteristic withdrawal syndrome for sedatives, hypnotics, or anxiolytics (refer to Criteria A and B of the criteria set for sedative. hypnotic, or anxiolytic withdrawal, pp. 557—558).
D. Sedatives, hypnotics, or anxiolytics (or a closely related substance, such as al- cohol) are taken to relieve or avoid withdrawal symptoms.
Note: This criterion is not considered to be met for individuals taking sedatives, hypnotics, or anxiolytics under medical supervision.
Specify it:
In early remission: After full criteria for sedative, hypnotic, or anxiolytic use disorder were previously met, none of the criteria for sedative, hypnotic, or anxiolytic use disor- der have been met for at least 3 months but for less than 12 months (with the exception that Criterion A4, “Craving, or a strong desire or urge to use the sedative, hypnotic, or anxiolytic,” may be met).